Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
adjuvant, alemtuzumab, alkylating, Amgen, Array, attended, Banerji, Beigene, bendamustine, Bentley, binimetinib, BioPharma, bloodstream, BMS, bortezomib, bowel, BRAF, breadth, CAR, carboplatin, Carlo, cetuximab, chemoimmunotherapy, chlorambucil, CHOEP, choice, Chugai, cobimetinib, cohort, colon, Commonwealth, concession, confined, CPS, CRC, curable, cycle, dabrafenib, derecognized, diffuse, disappointing, dismal, distal, doublet, driven, dyspnea, East, elderly, encorafenib, endometrial, Epizyme, ERK, ESPP, evolved, exam, explore, exploring, feedback, fibrosarcoma, fill, fludarabine, fluorouracil, frailty, Genentech, gland, Goodwill, hair, HCR, hear, HGSOC, HNSCC, Homolog, HPV, Hutchison, hyperglycemia, hypocalcemia, hyponatremia, hypophosphatemia, ICE, ifosfamide, imaging, implicit, incidentally, infusion, instability, intermittent, intestine, intraperiod, IST, land, LGSOC, Lily, linperlisib, locoregionally, LODER, lookback, lymphocytopenia, Matthew, MD, mechanism, MediPharma, melanoma, Middle, Mirati, moist, Monte, mouth, mucosal, mutant, mutation, myelosuppression, nivolumab, Northeastern, nose, objective, outbreak, paradoxically, parsaclisib, payroll, phosphorylation, plant, platinum, pMEK, prelude, problematic, purine, radiopharmaceutical, RAF, RAS, rectal, rectum, recurrence, recurrent, regular, remanded, residual, Richter, ripple, romidepsin, Russia, salivary, score, Shanghai, Silenseed, Sloan, social, speed, split, strain, streamline, Supreme, synergy, taxane, tazemetostat, TEMPO, Thirteen, Threshold, throat, thyroid, tiuxetan, TME, traditionally, troubled, Turkey, Udai, umbralisib, uncommon, undetectable, unique, unsatisfactory, vemurafenib, wall, white, Wuhan, Yingli, yttrium, zanubrutinib, Zeste
Removed:
acalisib, accrue, Adapted, advent, al, Berk, Borrower, breakdown, buparlisib, career, Coley, CombinatoRx, confirmed, coupled, debate, defining, dehydrogenase, demonstrable, England, explain, Flinn, Forma, Gregory, idea, informative, intermediate, ITT, Jonathan, journal, lactate, leased, led, Louise, marked, opportunistic, oversaw, Pachter, Phanstiel, poorly, presence, prognostic, proportionate, reconciling, representation, revealing, reversible, ruxolitinib, septic, shock, spent, tolerate, tranche, transaminase, viral, warranty
Filing tables
Filing exhibits
VSTM similar filings
Filing view
External links